← Back to Search

Supportive + Cognitive Behavioural Therapy for High Risk of Psychosis

N/A
Recruiting
Led By Jean M Addington, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 18 months
Awards & highlights

Study Summary

This trial will be testing whether different psychological interventions can prevent young people at risk for psychosis from developing the condition.

Who is the study for?
This trial is for young people who are at high risk of developing psychosis but haven't yet. They should not have had a psychotic disorder before, an IQ below 70, or significant brain-related health issues.Check my eligibility
What is being tested?
The study tests stepped care in youth at risk for psychosis. It starts with supportive therapy and can step up to intensive Cognitive Behavioral Therapy (CBT) if needed, with progress checks every 6 months.See study design
What are the potential side effects?
While the trial doesn't involve medication, psychological interventions like CBT may cause temporary discomfort such as increased anxiety or self-awareness during early treatment stages.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Scale of Psychosis Risk Symptoms
Secondary outcome measures
Global Functioning Scale: Social and Role

Trial Design

1Treatment groups
Experimental Treatment
Group I: Open treatmentExperimental Treatment1 Intervention
Supportive therapy followed by CBT

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
783 Previous Clinical Trials
845,869 Total Patients Enrolled
Jean M Addington, PhDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
203 Total Patients Enrolled

Media Library

Supportive therapy Clinical Trial Eligibility Overview. Trial Name: NCT04829292 — N/A
High Risk for Psychosis Research Study Groups: Open treatment
High Risk for Psychosis Clinical Trial 2023: Supportive therapy Highlights & Side Effects. Trial Name: NCT04829292 — N/A
Supportive therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04829292 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals is the maximum capacity of this clinical experiment?

"Affirmative. The trial's details, which were initially listed on September 1st 2021 and most recently updated on May 17th 2022, are available to view online via the clinicaltrials.gov website. This study is currently recruiting 60 individuals across a single site."

Answered by AI

Is it feasible for me to join this experiment?

"To meet the eligibility criteria for this investigation, participants must suffer from a form of psychosis and be between 13 to 25 years old. So far, approximately 60 individuals have been accepted into the study."

Answered by AI

Are individuals aged 45 and above eligible to participate in this medical research?

"According to the guidelines of this research, participants aged 13 to 25 are eligible for enrollment."

Answered by AI

Are there any available patient slots within this research project?

"Confirmed. The information on clinicaltrials.gov shows that the trial is still in search of participants and was initially listed on September 1st, 2021 with its most recent update being made earlier this month (May 17th)."

Answered by AI
~27 spots leftby Apr 2026